Filing Details

Accession Number:
0001104659-16-099476
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-24 12:05:12
Reporting Period:
2016-02-22
Filing Date:
2016-02-24
Accepted Time:
2016-02-24 12:05:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1628214 Lisa Alderson C/O Invitae Corporation
458 Brannan Street
San Francisco CA 94107
Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-22 7,500 $3.42 31,819 No 4 M Direct
Common Stock Disposition 2016-02-22 7,500 $7.64 24,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-02-22 7,500 $0.00 7,500 $3.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,833 2014-02-28 No 4 M Direct
Footnotes
  1. Represents weighted average sale price. Actual sale prices ranged from $7.5 to $7.85.
  2. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  3. The option became exercisable as to 25% of the shares on February 28, 2015, and becomes exercisable as to 1/48th of the shares each full month thereafter.